Latest Report with Titled “Autism Disorder & Treatment Market” Exclusively Available at MarketResearchFuture.com. Covered All the Segments and Sub Segments, Along With Top Industry Players and Geological Region. Growing Prevalence of Autistic & Related Disorders Has Enhanced the Autism Disorder & Treatment Market Growth Over the Forecast Period 2018 to 2023.
Market Highlights:
Growing burden of autism in western countries has majorly contributed to the growth of the market and is likely to increase due to growing number of cases of autism around the globe in the coming years which will also boost the market growth during the forecast period. Environmental and genetic factors are major factors which have majorly increased the prevalence of autism disorder, and it is expected to increase in the coming decade due to various factors such as poor nutritional conditions of children and adolescents, increasing environmental toxins and increasing prenatal and perinatal maternal stress.
Get Premium Sample Copy at https://www.marketresearchfuture.com/sample_request/1605
According to a recent epidemiological study, it has been observed that around 87% of the ASD cases are from Europe, Japan, and North America, while only 10% of the world’s children live in these countries. Moreover, the Centers for Disease Control’s (CDC) Autism and Developmental Disabilities Monitoring (ADDM) society stated that approximately 1 in 68 children in the United States was identified with an Autism Spectrum Disorder (ASD) in 2016.
Major Players in the Autism Disorder & Treatment Market:
Some of the key players in this market are Pfizer Inc., Eli Lilly and Company, Allergan, Merck & CO Inc., Teva Pharmaceutical Industries Ltd., Consern Pharma Private Limited, Novartis AG, Johnson & Johnson Services, Inc. Bristol-Myers Squibb and Otsuka Holdings Co., Ltd., Coronis Partners Ltd., Curemark LLC, Heptares Therapeutics Limited, Intra-Cellular Therapies Inc., and Saniona AB.
The global autism disorder & treatment market is segmented into four major regions including Americas, Europe, Asia Pacific and the Middle East & Africa.
The global autism disorder and treatment market has been identified as one of the rapidly growing industries, owing to rising prevalence of autism and Pervasive Developmental Disorder (PDD) and raising awareness about autism among the patient population. Autism disorder and treatment is observed as one of the significantly growing markets in the healthcare sector because of initiatives by the government of various nations and expected approvals of various off-label treatment therapies by the Food and Drug Association (FDA). With the upsurge in the market, there are some hindrances faced by the market such as a weak pipeline of drugs for autism disorder and unknown etiology and pathophysiology of ASD.
Have any Query, Ask to Experts at https://www.marketresearchfuture.com/enquiry/1605
Segmentation:
The global autism disorder & treatment market is segmented by type, treatment type, and drugs. On the basis of type, it is segmented into Asperger Syndrome, Pervasive Developmental Disorder, others. On the basis of treatment type, it is segmented into ABA (applied behavioral analysis), hyperbaric oxygen therapy, chelation therapy, oxytocin therapy and others. On the basis of drugs, it is segmented into SSRIs, anti-convulsant, stimulants, anti-psychotic. Anti-psychotics are further segmented into Abilify (aripiprazole) and Risperidone.
Major TOC of Autism Disorder and Treatment Market Research Report – Forecast to 2023:
1 REPORT PROLOGUE
2 MARKET INTRODUCTION
3 RESEARCH METHODOLOGY
4 MARKET DYNAMICS
5 MARKET FACTOR ANALYSIS
6 GLOBAL AUTISM DISORDER & TREATMENT MARKET, BY TYPE
7 GLOBAL AUTISM DISORDER & TREATMENT MARKET, BY TREATMENT TYPE
8 GLOBAL AUTISM DISORDER & TREATMENT MARKET, BY DRUGS
9 GLOBAL AUTISM DISORDER & TREATMENT MARKET, BY REGION
10 COMPETITIVE LANDSCAPE
11 COMPANY PROFILES
12 CONCLUSION
13 APPENDIX
Get Stunning Discount at https://www.marketresearchfuture.com/check-discount/1605
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312